Immunisation Community of Practice

Share Immunisation Community of Practice on Facebook Share Immunisation Community of Practice on Twitter Share Immunisation Community of Practice on Linkedin Email Immunisation Community of Practice link

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

  • NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers

    Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Facebook Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Twitter Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Linkedin Email NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers link

    Vaccines are recommended throughout an individual’s life to protect against vaccine-preventable diseases severity and complications. Increasingly more vaccines are becoming available and are recommended for use in adults. This guide aims to assist immunisation providers identify vaccines that can be co-administered in people aged 18 years and older.

    This guide should be used in conjunction with the Australian Immunisation Handbook and is available on the NCIRS website.

    Co-administration of vaccines for adults: a guide for immunisation providers

  • Flu Reimbursement Form now available

    Share Flu Reimbursement Form now available on Facebook Share Flu Reimbursement Form now available on Twitter Share Flu Reimbursement Form now available on Linkedin Email Flu Reimbursement Form now available link

    The Ministry of Health (MoH) have recently released information re the Reimbursement of private flu vaccines that were purchased for the “Free Flu Vaccine” in June/July program. Please contact your PCIO or myself if you did not receive this notification or require a copy of the form.

    Once the form is completed, all relevant invoices are to be attached and returned to to MOH-NSWHealth@health.nsw.gov.au by COB Friday 26 August 2022.

    The form states it is to be used by GPs. It has been clarified by the MoH, that one form should be submitted per practice, the person completing the form (who is listed as the contact person), should be the most appropriate person at the practice to assist with vendor set up. This person could be a practice manager, nurse or GP. One provider number can be listed even if that provider is not completing the form.

  • NSW Health advice: FluQuadri packaging

    Share NSW Health advice: FluQuadri packaging on Facebook Share NSW Health advice: FluQuadri packaging on Twitter Share NSW Health advice: FluQuadri packaging on Linkedin Email NSW Health advice: FluQuadri packaging link
    supporting image

    Sanofi have advised that some FluQuadri vaccine stock supplied into Australia has international packaging with eligibility wording “For 3 years of age and older” (see photo). This includes FluQuadri supplied for the NSW Government’s universal flu vaccine program for people aged 5-64 years, who are not otherwise eligible under the National Immunisation Program (NIP).

    The ATAGI statement of the administration of seasonal influenza vaccines in 2022 advises that FluQuadri may be given to children from 6 months of age.

    Sanofi advises that these batches were approved by the TGA for supply in Australia under s19A, and that Sanofi was required to send this advice to all GP practices before distributing.

    Provider reminder: ALL children aged 6 months to <5 years are eligible for free influenza vaccine under the NIP (Vaxigrip Tetra and Fluarix Tetra) as detailed in the ATAGI statement.

  • ATAGI updated recommendations for a winter dose of COVID-19 vaccine

    Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Facebook Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Twitter Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Linkedin Email ATAGI updated recommendations for a winter dose of COVID-19 vaccine link
    supporting image
    ATAGI has updated its recommendations for a winter dose of COVID-19 vaccine.
    These are:
    • Adults aged 50 to 64 years are now recommended to receive a winter booster dose of a COVID-19 vaccine.
    • Adults aged 30 to 49 years can receive a winter booster dose of a COVID-19 vaccine, however the benefit for people in this age group is less certain.
    • The interval recommended between a recent SARS-CoV-2 infection or the first booster dose and a winter booster dose is now 3 months.
    People previously eligible for a winter booster dose are at a higher risk of severe disease and death from COVID-19 and should receive a winter booster dose as soon as possible. ATAGI advises that individuals previously infected with SARS-CoV-2, irrespective of the variant, should continue to receive recommended vaccine doses, after an interval of 3 months. This is because a previous infection will not provide sufficient protection against severe disease.
    The full detailed recommendations are available on the Department of Health and Aged Care website.

  • Zostavax supply issues

    Share Zostavax supply issues on Facebook Share Zostavax supply issues on Twitter Share Zostavax supply issues on Linkedin Email Zostavax supply issues link

    The following item is posted on the Vaccine Ordering Centre website:

    Zostavax remains restricted due to national supply shortages. To ensure ongoing supply to all immunisation providers, ordering quantities will be restricted until supply issues stabilise.

  • Reimbursement for privately funded influenza vaccines

    Share Reimbursement for privately funded influenza vaccines on Facebook Share Reimbursement for privately funded influenza vaccines on Twitter Share Reimbursement for privately funded influenza vaccines on Linkedin Email Reimbursement for privately funded influenza vaccines link
    CLOSED: This discussion has concluded.
    supporting image

    General practices who privately purchased flu vaccines for the “NSW free flu vaccine in June/July” program, will be able to submit a declaration form at the conclusion of the program (17 July 2022) to seek remuneration for the purchase cost of quantities administered during 1 June to 17 July.

    Practices will need to complete one declaration form with attached invoices after 17 July 2022. The declaration form is still in development and will be circulated in July. As soon as the form becomes available, the PHN will update you.

    For now, practices should keep records of:

    1. invoices of privately purchased flu vaccines
    2. number of private flu vaccines administered during 1 June to 17 July

  • Influenza 2022

    Share Influenza 2022 on Facebook Share Influenza 2022 on Twitter Share Influenza 2022 on Linkedin Email Influenza 2022 link
    CLOSED: This discussion has concluded.
    supporting image

    NSW Health have announced that free flu shots for NSW residents will be extended until 17 July amid concerns vaccination rates are still not where they should be.

    Free flu vaccine in NSW

    The NSW Government will fund flu vaccinations for all NSW residents from 1 June 2022 to 17 July 2022 (previously 30 June) to boost immunity for the winter season. Free flu shots will be available at:

    • GP clinics for everyone aged 6 months and over
    • Pharmacies for everyone aged 5 years and over

    NSW Health media: Free flu shots for all in June
    NSW Health website: Influenza resources for health professionals

Page last updated: 05 Sep 2024, 02:55 PM